The report "Emergency Contraceptives Market by Drug Class (Combined estrogen and progestin pills, Progestin-only (as Levonorgestrel) pills, Antiprogestin (as mifepristone) pills, Ulipristal acetate pills), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others and Region - Global Forecasts to 2030", is projected to reach USD 30.2 billion in 2023, having...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian